Major Cardiovascular Events in Gout Patients with Cardiovascular Disease or Heart Failure and Chronic Kidney Disease Initiating on Allopurinol or Febuxostat (Uloric)

被引：0
|
作者：
Foody, JoAnne [1 ]
Turpin, Robin [2 ]
Tidwell, Beni [3 ]
Schulman, Kathy [4 ]
机构：
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
[2] Takeda Pharmaceut Int, Med Affairs, Deerfield, IL USA
[3] ORS, Shrewsbury, MA USA
[4] Outcomes Res Solut Inc, Waltham, MA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2356
引用
收藏
页数：2
相关论文
共 50 条
  • [1] MAJOR CARDIOVASCULAR EVENTS IN PATIENTS WITH RECURRENT GOUT, CARDIOVASCULAR AND CHRONIC KIDNEY DISEASE, INITIATING ON ALLOPURINOL OR FEBUXOSTAT
    Foody, J.
    Turpin, R.
    Tidwell, B. A.
    Lawrence, D. F. Eisenberg
    Schulman, K. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 374 - 374
  • [2] Major Cardiovascular Events in Patients with Gout and Associated Cardiovascular Disease or Heart Failure and Chronic Kidney Disease Initiating a Xanthine Oxidase Inhibitor
    Foody, JoAnne
    Turpin, Robin S.
    Tidwell, Beni A.
    Lawrence, Debra
    Schulman, Kathy L.
    AMERICAN HEALTH AND DRUG BENEFITS, 2017, 10 (08): : 393 - 400
  • [3] Cardiovascular Outcomes of Treatment with Febuxostat and Allopurinol in Gout Patients with Kidney Disease
    White, William B.
    Gunawardhana, Lhanoo
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [4] Febuxostat or Allopurinol in Patients with Gout Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES)
    Alten, R.
    Mischkewitz, M.
    Nitschmann, S.
    INTERNIST, 2020, 61 (05): : 530 - 532
  • [5] CARDIOVASCULAR EVENT ASSOCIATED WITH INITIATING ALLOPURINOL AND FEBUXOSTAT - ACUTE GOUT ATTACK AND CARDIOVASCULAR GOUT ATTACK
    Kim, H. J.
    Ahn, H. S.
    Kim, J.
    Ghang, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 106 - 106
  • [6] Comparative Cardiovascular Risks of Febuxostat and Allopurinol in Patients with Diabetes Mellitus and Chronic Kidney Disease
    Huang, Hsin Hsiang
    Chen, Yun-Yi
    Fang, Yu-Wei
    Liou, Hung-Hsiang
    Wang, Jing-Tong
    Tsai, Ming-Hsein
    MEDICAL SCIENCE MONITOR, 2024, 30
  • [7] Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
    White, William B.
    Saag, Kenneth G.
    Becker, Michael A.
    Borer, Jeffrey S.
    Gorelick, Philip B.
    Whelton, Andrew
    Hunt, Barbara
    Castillo, Majin
    Gunawardhana, Lhanoo
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13): : 1200 - 1210
  • [8] CArdiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular ComoRbiditiES
    White, William B.
    Chohan, Saima
    Dabholkar, Aruna
    Hunt, Barbara
    Jackson, Robert
    AMERICAN HEART JOURNAL, 2012, 164 (01) : 14 - 20
  • [9] Updated Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol
    Pawar, Ajinkya
    Desai, Rishi J.
    Liu, Jun
    Kim, Erin
    Kim, Seoyoung C.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (07):
  • [10] OCCURRENCE OF MAJOR CARDIOVASCULAR EVENTS IN PATIENTS WITH GOUT TREATED WITH FEBUXOSTAT
    Quilis, N.
    Andres, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1636 - 1636
12345